Literature DB >> 11295236

Dose-dependent induction of mRNAs encoding brain-derived neurotrophic factor and heat-shock protein-72 after cortical spreading depression in the rat.

Y M Rangel1, K Karikó, V A Harris, M E Duvall, F A Welsh.   

Abstract

Previous studies have demonstrated that cortical spreading depression (CSD) increases the expression of putative neuroprotective proteins. The objective of the present study was to elucidate the relationship between the number of episodes of CSD and steady-state levels of mRNAs encoding brain-derived neurotrophic factor (BDNF), heat-shock protein-72 (hsp72) and c-fos. Wistar rats were administered one, five, or twenty-five episodes of CSD evoked by application of 2 M KCl to the frontal cortex of one hemisphere. Animals were permitted to recover for 30 min, 2 h or 24 h prior to sacrifice. Total RNA was isolated from the parietal cortex of each hemisphere and analyzed using Northern blots. At 30 min recovery, levels of BDNF mRNA were not significantly elevated after 1 episode of CSD, but were increased 4-fold after five episodes of CSD and 11-fold after twenty-five episodes of CSD, relative to levels in the contralateral hemisphere. At 2 h recovery, BDNF mRNA levels increased 2-, 3- and 9-fold, respectively. At 24 h, BDNF mRNA had returned to control levels in all groups. Thus, CSD increased levels of BDNF mRNA in a dose-dependent fashion at the early recovery times. Hsp72 mRNA was below the level of detection after 1 and 5 episodes of CSD. However, after twenty-five episodes of CSD, hsp72 mRNA levels were increased in the ipsilateral hemisphere at 30 min and 2 h recovery. Unlike levels of BDNF and hsp72 mRNA, levels of c-fos mRNA were increased nearly to the same extent at 30 min and 2 h after one, five or twenty-five episodes of CSD before returning to control by 24 h recovery. These results demonstrate that CSD triggers a dose-dependent increase in the expression of genes encoding neuroprotective proteins, which may mediate tolerance to ischemia induced by CSD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295236     DOI: 10.1016/s0169-328x(01)00037-7

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

1.  Cerebral preconditioning using cortical application of hypertonic salt solutions: upregulation of mRNAs encoding inhibitors of inflammation.

Authors:  Hiromi Muramatsu; Frank A Welsh; Katalin Karikó
Journal:  Brain Res       Date:  2006-05-24       Impact factor: 3.252

2.  Immunomodulatory Effect of Toll-Like Receptor-3 Ligand Poly I:C on Cortical Spreading Depression.

Authors:  Amir Ghaemi; Azadeh Sajadian; Babak Khodaie; Ahmad Ali Lotfinia; Mahmoud Lotfinia; Afsaneh Aghabarari; Maryam Khaleghi Ghadiri; Sven Meuth; Ali Gorji
Journal:  Mol Neurobiol       Date:  2014-11-23       Impact factor: 5.590

3.  Induction of calcitonin gene-related peptide expression in rats by cortical spreading depression.

Authors:  Yan Wang; Anne E Tye; Junli Zhao; Dongqing Ma; Ann C Raddant; Fan Bu; Benjamin L Spector; Nolan K Winslow; Minyan Wang; Andrew F Russo
Journal:  Cephalalgia       Date:  2016-11-12       Impact factor: 6.292

4.  Association of brain-derived neurotrophic factor and nerve growth factor gene polymorphisms with susceptibility to migraine.

Authors:  Salih Coskun; Sefer Varol; Hasan H Ozdemir; Elif Agacayak; Birsen Aydın; Oktay Kapan; Mehmet Akif Camkurt; Saban Tunc; Mehmet Ugur Cevik
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-19       Impact factor: 2.570

Review 5.  Cortical spreading depression-induced preconditioning in the brain.

Authors:  Ping-Ping Shen; Shuai Hou; Di Ma; Ming-Ming Zhao; Ming-Qin Zhu; Jing-Dian Zhang; Liang-Shu Feng; Li Cui; Jia-Chun Feng
Journal:  Neural Regen Res       Date:  2016-11       Impact factor: 5.135

6.  Brain-derived neurotrophic factor in primary headaches.

Authors:  Marlene Fischer; Georg Wille; Stephanie Klien; Hind Shanib; Dagny Holle; Charly Gaul; Gregor Broessner
Journal:  J Headache Pain       Date:  2012-05-15       Impact factor: 7.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.